| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/04/2008 | CN100391942C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing same and their use in medicaments |
| 06/03/2008 | US7381842 For resist applications; thermostability, storage stability; color filters |
| 06/03/2008 | US7381840 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/03/2008 | US7381827 Processes and intermediates |
| 06/03/2008 | US7381742 Optically active polymaleimide derivatives and process for their production |
| 06/03/2008 | US7381741 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 06/03/2008 | US7381727 Pyrrole derivatives, their preparation and their therapeutic use |
| 06/03/2008 | CA2435954C Preparation of non-crystalline atorvastatin calcium |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2305760C Inhibitors of nucleoside metabolism |
| 05/29/2008 | WO2008062252A1 N-oxides of cytotoxic anthraquinones as hypoxia-targeting prodrugs in cancer treatment |
| 05/29/2008 | WO2008061399A1 Fatty acid synthase inhibitor and its use |
| 05/29/2008 | WO2008021029A3 Process for making lactam tachykinin receptor antagonists |
| 05/29/2008 | US20080125601 Key steps in the synthesis are early introduction of the correct absolute stereochemistry at C-3 (R) and subsequent regioselective chain lengthening; Unlike the linear synthesis processes in the prior art, the use of the novel statin side chain building blocks allows a convergent synthesis |
| 05/29/2008 | US20080125598 No racemization during cyclization, decarbalkoxylation, decarboxylation of intermediate; separation of diastereoisomers by recrystallization; no use of toxic, expensive catalysts; Levetiracetam; treatment, prevention of hypoxic, ischemia of central nervous system |
| 05/29/2008 | US20080125597 Method Of Preparation Of Maleimides By Thermal Cyclization Of Maleamic Acids In The Presence Of A Catalyst |
| 05/29/2008 | US20080125589 Process for Production of Fluoro Derivative |
| 05/29/2008 | US20080125484 Synthetic Lactone Formulations and Methods of Use |
| 05/29/2008 | US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 05/29/2008 | US20080125444 Acyclic oximyl hepatitis c protease inhibitors |
| 05/29/2008 | US20080125375 Peptide like compounds for treating coronavirus or aviviridae virus; severe acute respiratory distress syndrome |
| 05/29/2008 | US20080125350 Branched polyalkylene glycols |
| 05/28/2008 | EP1924594A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 05/28/2008 | EP1924575A1 Anthranilamides for controlling invertebrate pests |
| 05/28/2008 | EP1924556A2 Crystalline forms of atorvastatin |
| 05/28/2008 | EP1924555A1 Crystalline and amorphous sodium atorvastatin |
| 05/28/2008 | EP1924554A1 Sulphonamide derivatives |
| 05/28/2008 | EP1673078B1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | CN101189229A Synthesis of avrainvillamide, stephacidin B, and analogues thereof |
| 05/28/2008 | CN101189012A Phenyl and pyridyl LTA4H modulators |
| 05/28/2008 | CN101186612A Pyrroline derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN101186611A Pyrroline-2-one derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN101186592A Dipyrrolidine-2,5-diketone-n-alkane compound containing diene group and its synthesizing method and use |
| 05/28/2008 | CN100390164C Isoquinoline compounds and medicinal use thereof |
| 05/28/2008 | CN100390144C Process for preparing 1-methyl-5-p-toluoylpyrroel-2-acetamidoacetic acid guaiacyl ester |
| 05/27/2008 | US7378525 CCR8 inhibitors |
| 05/27/2008 | US7378440 Antidiabetic agents; therapy for insulin resistance |
| 05/27/2008 | US7378436 Substituted N-[pyrrolidin-3-yl] benzamides or naphthamides; serotonin and noradrenaline receptor antagonists; urinary incontinence; arylation of the amino pyrrolidine with a carboxylic acid or acyl halide and then deprotecting |
| 05/27/2008 | US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 05/27/2008 | US7378161 Organometallic complexes and organic electroluminescence device using the same |
| 05/27/2008 | CA2272063C Antithrombotic organic nitrates |
| 05/22/2008 | WO2008059239A1 Novel compounds 514 |
| 05/22/2008 | WO2008011392A3 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 05/22/2008 | WO2008001195A3 Novel processes for the preparation of dpp iv inhibitors |
| 05/22/2008 | WO2007147770A3 Substituted phenyl methanone derivatives |
| 05/22/2008 | WO2007127725A3 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods |
| 05/22/2008 | WO2007051603A3 Kit comprising 2, 4- dichlorophenoxyacetic acd derivatives and antibodies for highly sensitive detection assays |
| 05/22/2008 | US20080119658 Histone deacetylase inhibitors |
| 05/22/2008 | US20080119537 5-Aryl indan-1 one and analogs useful as progesterone receptor modulators |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119476 Cetp Inhibitors |
| 05/22/2008 | US20080119464 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 05/21/2008 | EP1756095B1 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 05/21/2008 | EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/21/2008 | EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | CN101184728A Peptide deformylase (PDF) inhibitors 4 |
| 05/21/2008 | CN101184405A Beverages and foodstuffs resistant to light induced flavour changes, processes for making the same, and compositions for imparting such resistance |
| 05/21/2008 | CN101182308A Imidazole chiral ionic liquids containing double function groups as well as preparation method and uses thereof |
| 05/21/2008 | CN101182305A Method for synthesizing 2,5-disubstituted tetrahydrofuran derivatives |
| 05/21/2008 | CN101182304A Method for preparing N-alkyl pyrrolidine |
| 05/20/2008 | US7375238 Process for the preparation of N-substituted 2-cyanopyrrolidines |
| 05/20/2008 | US7375133 Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 05/20/2008 | US7375093 Nuclear receptor-based inducible gene expression system |
| 05/20/2008 | CA2473759C Antibodies for detecting ecstasy-class analytes |
| 05/20/2008 | CA2419698C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/15/2008 | WO2008058138A2 Method for cooperative transport of parcels |
| 05/15/2008 | WO2008057775A2 Heterocyclic amide compounds useful as kinase inhibitors |
| 05/15/2008 | WO2008057282A1 Calcium receptor modulating agents |
| 05/15/2008 | WO2008055847A1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors |
| 05/15/2008 | US20080114169 Intermediates of active esters for peptide synthesis, labeling, analysis; purity |
| 05/15/2008 | US20080114052 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/15/2008 | US20080114051 Pyrrolidine derivatives as prostaglandin modulators |
| 05/15/2008 | US20080114037 Histone deacetylase inhibitors |
| 05/15/2008 | US20080114030 Diarymethyl and related compounds |
| 05/15/2008 | US20080113995 1-Cyclopentyl-4-{2-[5-(4-methanesulfonylphenyl)[1,2,4]oxadiazol-3-yl]ethyl}piperidine; histamine-H3 receptor antagonist or inverse agonist; nervous system, cardiovascular , respiratory system, gastrointestinal system and endocrinological system disorders |
| 05/15/2008 | US20080113976 asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis; Azetidine-1-carboxylic acid {2-[({2-hydroxy-1-[(isopropyl-methyl-amino)-methyl]-pentylcarbamoyl}-methyl)-carbamoyl]-4-trifluoromethyl-phenyl}-amide |
| 05/15/2008 | US20080113975 Thiourea compounds |
| 05/15/2008 | US20080112866 Functionalized ionic liquids, and methods of use thereof |
| 05/15/2008 | DE19753655B4 α-Aminoacetophenonverbindungen, Massen, die diese Verbindungen enthalten und deren Verwendung als Photostarter α-Aminoacetophenonverbindungen, compositions containing these compounds and their use as photoinitiators |
| 05/15/2008 | CA2667710A1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1919865A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 05/14/2008 | EP1919864A2 Fap inhibitors |
| 05/14/2008 | EP1575922B1 Biphenyl derivatives and their use as fungicides |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/14/2008 | CN101180272A Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same |
| 05/14/2008 | CN101180271A Process for producing carbapenem derivative having a 1-alkylpyrrolidine structure |
| 05/14/2008 | CN101177411A Method for synthesizing non-steroidal antiphlogiston tolmetin |
| 05/14/2008 | CN101177410A Method for synthesizing 2-substituted enamine or enamides |
| 05/14/2008 | CN101177370A Method for synthesizing heteroaromatic carboxylate and heterocyclic amino acid |
| 05/13/2008 | US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl |
| 05/13/2008 | US7371855 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 05/13/2008 | US7371767 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 05/08/2008 | WO2008055236A2 Mapk/erk kinase inhibitors |
| 05/08/2008 | WO2008053495A1 A novel crystalline form of atorvastatin sodium |
| 05/08/2008 | WO2008053324A1 An improved process for the preparation of gemifloxacin mesylate |